Provides for the selection through competitive bidding of eligible providers of such prescription drugs and biological products (covered outpatient drugs) in a particular coverage area. Requires an eligible beneficiary not enrolled in a Medicare+Choice plan under Medicare part C (Medicare+Choice) to enroll with an eligible entity under this Act to be eligible to receive covered outpatient drugs under Medicare part B. Mandates appropriate outreach activities by the Secretary of Health and Human Services.
Outlines cost-sharing requirements establishing an annual deductible of $250.00 and specified co-payments (with no co-payment for generic drugs). Allows the use of formularies, generic drug substitution, and other mechanisms to provide benefits economically.
Directs the Secretary to: (1) establish a model for comprehensive educational programs to assure appropriate prescribing, dispensing, and use of such covered drugs; and (2) enter into an arrangement with the Institute of Medicine of the National Academy of Sciences for analysis of such new benefit and annual reports to the Secretary and Congress on its effectiveness in reducing demand for acute medical services, as well as its annual cost and resulting savings. Provides for appropriate funding for such analyses.
Amends SSA title XIX (Medicaid) to provide for Medicaid coverage of the new Medicare part B prescription drug benefit cost-sharing for certain individuals who would be qualified Medicare beneficiaries but for their income which exceeds the level established by the State but is less than a certain percentage of the official poverty line for a family of the size involved.
Introduced in House
Introduced in House
Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor introductory remarks on measure. (CR E968)
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health and Environment.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line